Proliferation of dental pulp fibroblasts in response to thrombin involves mitogen-activated protein kinase signalling

Int Endod J. 2004 Feb;37(2):145-50. doi: 10.1111/j.0143-2885.2004.00777.x.

Abstract

Aim: To examine the involvement of mitogen-activated protein kinases (MAPK) signalling on thrombin-stimulated human dental pulp fibroblasts (DPF).

Methodology: Dental pulp fibroblasts were isolated from dental pulp connective tissue of third molars and expanded in vitro. Expression of thrombin receptors was analysed by RT-PCR, and cell proliferation was measured by 3[H]-thymidine incorporation assay. Phosphorylation levels of MAPK were determined by Western blot analysis, and alkaline phosphatase activity was measured to serve as a marker for odontogenic differentiation. Statistical analysis was performed by Student's t-test.

Results: Dental pulp fibroblasts express the thrombin receptors protease-activated receptor-1 (PAR-1), PAR-3 and PAR-4. Measurement of 3[H]-thymidine incorporation revealed a dose-dependent increase of DNA synthesis in response to thrombin treatment. The thrombin-induced mitogenic activity was decreased by the extracellular signal-regulated protein kinase (ERK) signalling inhibitor PD98059 (P < 0.05), and by SB203580 (P < 0.05), a p38 MAPK inhibitor. Western blot analysis demonstrated increased phosphorylation of ERK in DPF following stimulation with thrombin, while p38 MAPK and c-Jun NH2-terminal kinase (JNK) were not activated. Alkaline phosphatase activity of DPF remained unchanged upon incubation with thrombin.

Conclusions: These results suggest that signalling via MAPK mediates the mitogenic activity of thrombin on DPF and may thus play a role during the early stages of pulp repair.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blotting, Western
  • Cell Division / drug effects
  • Cells, Cultured
  • Dental Pulp / cytology
  • Dental Pulp / drug effects*
  • Dental Pulp / enzymology
  • Fibroblasts / drug effects
  • Fibroblasts / enzymology
  • Humans
  • MAP Kinase Signaling System / drug effects*
  • MAP Kinase Signaling System / physiology*
  • Middle Aged
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / metabolism
  • Phosphorylation
  • RNA / biosynthesis
  • Receptors, Thrombin / biosynthesis*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Thrombin / pharmacology*
  • Thrombin / physiology
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Receptors, Thrombin
  • RNA
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Thrombin